V242F (p.Val242Phe) variant of SGCA (Alpha-sarcoglycan)

V242F (p.Val242Phe) in SGCA (Alpha-sarcoglycan) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of Autosomal recessive limb-girdle muscular dystrophy. The available variant effect predictions contribute to a CATVariant prioritization score of 0.60 / 1. The record also includes population frequency data and structural context.

V242F (p.Val242Phe) variant details